Kabbinavar, Fairooz
Cardiff Oncology Inc.,
United States
2024 Rank: 197891
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 6581 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 197891 | 225610 |
| Total Cites | 1473 | 1500 |
| H-index | 13 | 13 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 43 | 46 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 310 | 315 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1338 | 1359 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
1.80%
|
|
Kabbinavar, Fairooz
Ronald Reagan UCLA Medical Center,
United States
2022 Rank: 133565
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 5026 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133565 | 155433 |
| Total Cites | 1805 | 1867 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 58 | 60 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 337 | 341 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1645 | 1699 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
3.32%
|
|
Kabbinavar, Fairooz
Puma Biotechnology, Inc.,
United States
2021 Rank: 113979
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4065 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113979 | 130969 |
| Total Cites | 2834 | 2965 |
| H-index | 17 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 93 | 98 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 566 | 577 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2539 | 2644 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.12 |
| Self-Citation Percentage |
4.42%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.